Avenge Bio Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Avenge Bio is a biotechnology company focused on developing therapies for solid tumors. It is pursuing a precision delivery approach that administers potent immune-modulating molecules in a controlled, time-limited manner to generate robust local and systemic anti-tumor responses while aiming to limit toxicities seen with traditional immunotherapies. The goal is to address hard-to-treat solid cancers by shaping the immune response to target tumors in situ and systemically, potentially improving outcomes for patients.

Based in Natick, Massachusetts, the company was founded by an experienced team of biotech executives and is pursuing a broad pipeline across difficult solid tumors. The work centers on delivering immune-modulating agents via a platform-enabled approach to achieve targeted anti-tumor activity with reduced systemic toxicity. A notable recent development is FDA Fast Track designation for AVB-001, signaling progress for its lead program.

Get verified Avenge Bio emails free

Company overview Employee directory